NCT05487300View on ClinicalTrials.gov

Effect of Levodopa on Cardiovascular Autonomic Function in Parkinson's Disease

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 11, 2022

Primary Completion Date

May 1, 2023

Study Completion Date

May 1, 2023

Conditions
Parkinson DiseaseOrthostatic Hypotension
Interventions
DRUG

Autonomic testing on and off levodopa

"Participants with Parkinson's disease with and without orthostatic hypotension will undergo standardized autonomic testing on two separate days on levodopa and off levodopa."

Trial Locations (1)

84108

University of Utah, Salt Lake City

All Listed Sponsors
lead

University of Utah

OTHER